Buscar
01/09/2021
Molecular mapping of platelet hyperreactivity in diabetes: the stress proteins complex HSPA8/Hsp90/CSK2 alpha and platelet aggregation in diabetic and normal platelets
Chiva-Blanch, G, Pena, E, Cubedo, J, Garcia-Arguinzonis, M, Pane, A, Gil, PA, Perez, A, Ortega, E, Padro, T, Badimon, L. Molecular mapping of platelet hyperreactivity in diabetes: the stress proteins complex HSPA8/Hsp90/CSK2 alpha and platelet aggregation in diabetic and normal platelets. Translational Research. 2021; 235DOI:10.1016/j.trsl.2021.04.003. PMID:33887528. IF:10.171(Q1/1D).
01/09/2021
Psychometric Validation of the Cardiff Wound Impact Schedule Questionnaire in a Spanish Population with Diabetic Foot Ulcer
Granado-Casas, M, Martinez-Gonzalez, D, Martinez-Alonso, M, Doria, M, Alcubierre, N, Valls, J, Julve, J, Verdu-Soriano, J, Mauricio, D. Psychometric Validation of the Cardiff Wound Impact Schedule Questionnaire in a Spanish Population with Diabetic Foot Ulcer. Journal of Clinical Medicine. 2021; 10(17)DOI:10.3390/jcm10174023. PMID:34501471. IF:4.964(Q2/4D).
01/09/2021
Performance of early pregnancy HbA(1c) for predicting gestational diabetes mellitus and adverse pregnancy outcomes in obese European women (vol 168, 108378, 2020)
Immanuel, J, Simmons, D, Desoye, G, Corcoy, R, Adelantado, JM, Devlieger, R, Lapolla, A, Dalfra, MG, Bertolotto, A, Harreiter, J, Wender-Ozegowska, E, Zawiejska, A, Dunne, FP, Damm, P, Mathiesen, ER, Jensen, DM, Andersen, LLT, Hill, DJ, Jelsma, JGM, Snoek, FJ, Scharnagl, H, Galjaard, S, Kautzky-Willer, A, Van Poppel, MNM. Performance of early pregnancy HbA(1c) for predicting gestational diabetes mellitus and adverse pregnancy outcomes in obese European women (vol 168, 108378, 2020). DIABETES RESEARCH AND CLINICAL PRACTICE. 2021; 179DOI:10.1016/j.diabres.2021.109023. PMID:34479741. IF:8.180(Q1/2D).
01/09/2021
Cost Analysis of FreeStyle Libre(R) 2 System in Type 2 Diabetes Mellitus Population
Oyaguez, I, Gomez-Peralta, F, Artola, S, Carrasco, FJ, Carretero-Gomez, J, Garcia-Soidan, J, Gomez-Huelgas, R, Merino-Torres, JF, Perez, A. Cost Analysis of FreeStyle Libre(R) 2 System in Type 2 Diabetes Mellitus Population. Diabetes Therapy. 2021; 12(9)DOI:10.1007/s13300-021-01064-4. PMID:33948909. IF:3.605(Q3/7D).
01/09/2021
ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy
Luger, A, Broersen, LHA, Biermasz, NR, Biller, BMK, Buchfelder, M, Chanson, P, Jorgensen, JOL, Kelestimur, F, Llahana, S, Maiter, D, Mintziori, G, Petraglia, F, Verkauskiene, R, Webb, SM, Dekkers, OM. ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2021; 185(3)DOI:10.1530/EJE-21-0462. PMID:34425558. IF:6.558(Q1/2D).
01/09/2021
Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain
Iglesias, P, Nocete, I, Rodriguez, MDM, Venegas-Moreno, E, Ares, J, Biagetti, B, Berrocal, VR, Guerrero-Perez, F, Vicente, A, Villar-Taibo, R, Cordido, F, Paja, M, Glerean, M, Rivera, NG, Fuentes, ED, Blanco, C, Alvarez-Escola, C, Martin, T, Webb, SM, Bernabeu, I, Villabona, C, Soto-Moreno, A, Gaztambide, S, Diez, JJ. Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain. NEUROENDOCRINOLOGY. 2021; 111(10)DOI:10.1159/000512161. PMID:33040060. IF:5.135(Q2/4D).
01/09/2021
Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis
Villanueva, C, Albillos, A, Genesca, J, Garcia-Pagan, JC, Brujats, A, Calleja, JL, Aracil, C, Banares, R, Morillas, RM, Poca, M, Penas, B, Augustin, S, Abraldes, JG, Alvarado, E, Torres, F, Bosch, J. Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis. JOURNAL OF HEPATOLOGY. 2021; 75(3)DOI:10.1016/j.jhep.2021.04.022. PMID:33905794. IF:30.083(Q1/1D).
01/09/2021
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
Ampuero, J, Aller, R, Gallego-Duran, R, Crespo, J, Abad, J, Gonzalez-Rodriguez, A, Gomez-Camarero, J, Caballeria, J, Lo Iacono, O, Ibanez, L, Garcia-Samaniego, J, Martin-Mateos, R, Frances, R, Fernandez-Rodriguez, C, Diago, M, Soriano, G, Andrade, RJ, Latorre, R, Jorquera, F, Morillas, RM, Escudero, D, Estevez, P, Hernandez-Guerra, M, Augustin, S, Pareja-Megia, MJ, Banales, JM, Aspichueta, P, Benlloch, S, Rosales, JM, Salmeron, J, Turnes, J, Romero-Gomez, M. Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects. LIVER INTERNATIONAL. 2021; 41(9)DOI:10.1111/liv.14898. PMID:33896100. IF:8.754(Q1/2D).
01/09/2021
Metabolomics profiling predicts outcome of tocilizumab in rheumatoid arthritis: an exploratory study
Murillo-Saich, JD, Diaz-Torne, C, Ortiz, MA, Coras, R, Gil-Alabarse, P, Pedersen, A, Corominas, H, Vidal, S, Guma, M. Metabolomics profiling predicts outcome of tocilizumab in rheumatoid arthritis: an exploratory study. Metabolomics. 2021; 17(9)DOI:10.1007/s11306-021-01822-2. PMID:34402961. IF:4.747(Q2/4D).
01/09/2021
Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD
de-Torres, JP, O'Donnell, DE, Marin, JM, Cabrera, C, Casanova, C, Marin, M, Ezponda, A, Cosio, BG, Martinez, C, Solanes, I, Fuster, A, Neder, JA, Gonzalez-Gutierrez, J, Celli, BR. Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD. CHEST. 2021; 160(3)DOI:10.1016/j.chest.2021.04.033. PMID:33901498. IF:11.393(Q1/1D).
01/09/2021
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV
Gonzalez-Cordon, A, Assoumou, L, Moyle, G, Waters, L, Johnson, M, Domingo, P, Fox, J, Stellbrink, HJ, Guaraldi, G, Masia, M, Gompels, M, De Wit, S, Florence, E, Esser, S, Raffi, F, Behrens, G, Pozniak, A, Gatell, JM, Martinez, E. Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021; 76(9)DOI:10.1093/jac/dkab158. PMID:34120186. IF:5.758(Q1/2D).
01/09/2021
Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study
Blackhall, F, Jao, K, Greillier, L, Cho, BC, Penkov, K, Reguart, N, Majem, M, Nackaerts, K, Syrigos, K, Hansen, K, Schuette, W, Cetnar, J, Cappuzzo, F, Okamoto, I, Erman, M, Langer, SW, Kato, T, Groen, H, Sun, ZW, Luo, Y, Tanwani, P, Caffrey, L, Komarnitsky, P, Reinmuth, N. Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study. Journal of Thoracic Oncology. 2021; 16(9)DOI:10.1016/j.jtho.2021.02.009. PMID:33607312. IF:20.121(Q1/1D).
01/09/2021
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology
Garrido, P, Paz-Ares, L, Majem, M, Moran, T, Trigo, JM, Bosch-Barrera, J, Garcia-Campelo, R, Gonzalez-Larriba, JL, Sanchez-Torres, JM, Isla, D, Vinolas, N, Camps, C, Insa, A, Juan, O, Massuti, B, Paredes, A, Artal, A, Lopez-Brea, M, Palacios, J, Felip, E. LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology. Cancer Medicine. 2021; 10(17)DOI:10.1002/cam4.4135. PMID:34296539. IF:4.711(Q2/5D).
01/09/2021
Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and Europe
Vokinger, KN, Hwang, TJ, Daniore, P, Lee, CC, Tibau, A, Grischott, T, Rosemann, TJ, Kesselheim, AS. Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and Europe. JAMA Oncology. 2021; 7(9)DOI:10.1001/jamaoncol.2021.2026. PMID:34196656. IF:33.012(Q1/1D).
01/09/2021
Pharmacokinetics and safety of capmatinib with food in patients with MET-dysregulated advanced solid tumors
Moreno, V, Greil, R, Yachnin, J, Majem, M, Wermke, M, Arkenau, HT, Basque, JR, Nidamarthy, PK, Kapoor, S, Cui, XM, Giovannini, M. Pharmacokinetics and safety of capmatinib with food in patients with MET-dysregulated advanced solid tumors. CLINICAL THERAPEUTICS. 2021; 43(6)DOI:10.1016/j.clinthera.2021.04.006. PMID:34053700. IF:3.637(Q2/5D).
01/09/2021
Risk of contagion of SARS-CoV-2 among otorhinolaryngologists in Spain during the "Two waves"
Martin-Villares, C, Bernal-Sprekelsen, M, Molina-Ramirez, CP, Bartolome-Benito, M, Orus, C, Escamilla Carpintero, Yolanda. Risk of contagion of SARS-CoV-2 among otorhinolaryngologists in Spain during the "Two waves". EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2021; 278(9)DOI:10.1007/s00405-020-06582-8. PMID:33464400. IF:3.236(Q2/3D).
01/09/2021
The EHA Research Roadmap: Malignant Myeloid Diseases
Dohner, H, Malcovati, L, Ossenkoppele, GJ, Hochhaus, A, Vannucchi, AM, Bullinger, L, Cervantes, F, Craddock, C, de Witte, T, Dohner, K, Dombret, H, Fenaux, P, Geissler, J, Germing, U, Guilhot, F, Harrison, C, Hellstrom-Lindberg, E, Passamonti, F, Sierra, J, Skoda, R, Wierzbowska, A. The EHA Research Roadmap: Malignant Myeloid Diseases. Hemasphere. 2021; 5(9)DOI:10.1097/HS9.0000000000000635. PMID:34476345. IF:8.300(Q1/2D).
01/09/2021
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial
Larson, RA, Mandrekar, SJ, Huebner, LJ, Sanford, B, Laumann, K, Geyer, S, Bloomfield, CD, Thiede, C, Prior, TW, Dohner, K, Marcucci, G, Voso, MT, Klisovic, RB, Galinsky, I, Wei, AH, Sierra, J, Sanz, MA, Brandwein, JM, de Witte, T, Niederwieser, D, Appelbaum, FR, Medeiros, BC, Tallman, MS, Krauter, J, Schlenk, RF, Ganser, A, Serve, H, Ehninger, G, Amadori, S, Gathmann, I, Dohner, H, Stone, RM. Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial. LEUKEMIA. 2021; 35(9)DOI:10.1038/s41375-021-01179-4. PMID:33654204. IF:12.897(Q1/1D).
01/09/2021
European Stroke Organisation (ESO) standard operating procedure for the preparation and publishing of guidelines
Steiner, T, Dichgans, M, Norrving, B, Aamodt, AH, Berge, E, Christensen, H, Fuentes, B, Khatri, P, Korompoki, E, Marti-Fabregas, J, Quinn, T, Toni, D, Zedde, M, Sacco, S, Turc, G. European Stroke Organisation (ESO) standard operating procedure for the preparation and publishing of guidelines. European Stroke Journal. 2021; 6(3)DOI:10.1177/23969873211024143. PMID:34746429. IF:5.894(Q1/2D).
01/09/2021
Bottlenecks in the Acute Stroke Care System during the COVID-19 Pandemic in Catalonia
Ramos-Pachon, A, Garcia-Tornel, A, Millan, M, Ribo, M, Amaro, S, Cardona, P, Marti-Fabregas, J, Roquer, J, Silva, Y, Ustrell, X, Purroy, F, Gomez-Choco, M, Zaragoza-Brunet, J, Canovas, D, Krupinski, J, Sala, NM, Palomeras, E, Cocho, D, Redondo, L, Repullo, C, Sanjurjo, E, Carrion, D, Lopez, M, Almendros, MC, Barcelo, M, Monedero, J, Catena, E, Rybyeba, M, Diaz, G, Jimenez-Fabrega, X, Sola, S, Hidalgo, V, Pueyo, MJ, de la Ossa, NP, Urra, X. Bottlenecks in the Acute Stroke Care System during the COVID-19 Pandemic in Catalonia. CEREBROVASCULAR DISEASES. 2021; 50(5)DOI:10.1159/000516309. PMID:34023822. IF:3.104(Q3/6D).
01/09/2021
Effectiveness of Thrombectomy in Stroke According to Baseline Prognostic Factors: Inverse Probability of Treatment Weighting Analysis of a Population-Based Registry
Rudilosso, S, Rios, J, Rodriguez, A, Gomis, M, Vera, V, Gomez-Choco, M, Renu, A, Matos, N, Llull, L, Purroy, F, Amaro, S, Terceno, M, Obach, V, Serena, J, Marti-Fabregas, J, Cardona, P, Molina, C, Rodriguez-Campello, A, Canovas, D, Krupinski, J, Ustrell, X, Torres, F, San Roman, L, Salvat-Plana, M, Jimenez-Fabrega, FX, Palomeras, E, Catena, E, Colom, C, Cocho, D, Baiges, J, Aragones, JM, Diaz, G, Costa, X, Almendros, MC, Rybyeba, M, Barcelo, M, Carrion, D, Lopez, MN, Sanjurjo, E, de la Ossa, NP, Urra, X, Chamorro, A. Effectiveness of Thrombectomy in Stroke According to Baseline Prognostic Factors: Inverse Probability of Treatment Weighting Analysis of a Population-Based Registry. Journal of Stroke. 2021; 23(3)DOI:10.5853/jos.2021.00962. PMID:34649384. IF:8.632(Q1/1D).
01/09/2021
Reasons for Not Performing Mechanical Thrombectomy A Population-Based Study of Stroke Codes
Guisado-Alonso, D, Martinez-Domeno, A, Prats-Sanchez, L, Delgado-Mederos, R, Camps-Renom, P, Abilleira, S, De la Ossa, NP, Ramos-Pachon, A, Cardona, P, Rodriguez-Campello, A, Molina, CA, Rudilosso, S, Marti-Fabregas, J. Reasons for Not Performing Mechanical Thrombectomy A Population-Based Study of Stroke Codes. STROKE. 2021; 52(9)DOI:10.1161/STROKEAHA.120.032648. PMID:34289711. IF:10.170(Q1/1D).
01/09/2021
Replication study of plasma proteins relating to Alzheimer's pathology
Shi, L, Winchester, LM, Westwood, S, Baird, AL, Anand, SN, Buckley, NJ, Hye, A, Ashton, NJ, Bos, I, Vos, SJB, ten Kate, M, Scheltens, P, Teunissen, CE, Vandenberghe, R, Gabel, S, Meersmans, K, Engelborghs, S, De Roeck, EE, Sleegers, K, Frisoni, GB, Blin, O, Richardson, JC, Bordet, R, Molinuevo, JL, Rami, L, Wallin, A, Kettunen, P, Tsolaki, M, Verhey, F, Lleo, A, Sala, I, Popp, J, Peyratout, G, Martinez-Lage, P, Tainta, M, Johannsen, P, Freund-Levi, Y, Frolich, L, Dobricic, V, Legido-Quigley, C, Barkhof, F, Andreasson, U, Blennow, K, Zetterberg, H, Streffer, J, Lill, CM, Bertram, L, Visser, PJ, Kolb, HC, Narayan, VA, Lovestone, S, Nevado-Holgado, AJ. Replication study of plasma proteins relating to Alzheimer's pathology. ALZHEIMERS & DEMENTIA. 2021; 17(9)DOI:10.1002/alz.12322. PMID:33792144. IF:16.655(Q1/1D).
01/09/2021
AMYQ: An index to standardize quantitative amyloid load across PET tracers
Pegueroles, J, Montal, V, Bejanin, A, Vilaplana, E, Aranha, M, Santos-Santos, MA, Alcolea, D, Carrio, I, Camacho, V, Blesa, R, Lleo, A, Fortea, J. AMYQ: An index to standardize quantitative amyloid load across PET tracers. ALZHEIMERS & DEMENTIA. 2021; 17(9)DOI:10.1002/alz.12317. PMID:33797846. IF:16.655(Q1/1D).
01/09/2021
Selective estrogen receptor modulators (SERMs) affect cholesterol homeostasis through the master regulators SREBP and LXR
Fernandez-Suarez, ME, Daimiel, L, Villa-Turegano, G, Pavon, MV, Busto, R, Escola-Gil, JC, Platt, FM, Lasuncion, MA, Martinez-Botas, J, Gomez-Coronado, D. Selective estrogen receptor modulators (SERMs) affect cholesterol homeostasis through the master regulators SREBP and LXR. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2021; 141DOI:10.1016/j.biopha.2021.111871. PMID:34225017. IF:7.419(Q1/1D).
28/08/2021
Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review
Palacio-Vieira, J, Reyes-Uruena, JM, Imaz, A, Bruguera, A, Force, L, Llaveria, AO, Llibre, JM, Vilaro, I, Borras, FH, Falco, V, Riera, M, Domingo, P, de Lazzari, E, Miro, JM, Casabona, J, Gurgui M., Hernandez, J.. Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review. BMC PUBLIC HEALTH. 2021; 21(1)DOI:10.1186/s12889-021-11613-y. PMID:34454444. IF:4.135(Q2/4D).
26/08/2021
Circulating microRNAs in Early Breast Cancer Patients and Its Association With Lymph Node Metastases
Escuin, D, Lopez-Vilaro, L, Mora, J, Bell, O, Moral, A, Perez, I, Arqueros, C, Garcia-Valdecasas, B, Cajal, TRY, Lerma, E, Barnadas, A. Circulating microRNAs in Early Breast Cancer Patients and Its Association With Lymph Node Metastases. Frontiers in Oncology. 2021; 11DOI:10.3389/fonc.2021.627811. PMID:34513655. IF:5.738(Q2/4D).
24/08/2021
Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
Grigorian-Shamagian, L, Edel, K, Esteve-Pastor, MA, Acena, A, Silva, C, Delgado-Silva, J, Ntaios, G, Demerouti, E, Brotons, C. Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe. Frontiers in Cardiovascular Medicine. 2021; 8DOI:10.3389/fcvm.2021.663361. PMID:34504874. IF:5.848(Q2/4D).
19/08/2021
Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients
Solana, E, Martinez-Heras, E, Montal, V, Vilaplana, E, Lopez-Soley, E, Radua, J, Sola-Valls, N, Montejo, C, Blanco, Y, Pulido-Valdeolivas, I, Sepulveda, M, Andorra, M, Berenguer, J, Villoslada, P, Martinez-Lapiscina, EH, Prados, F, Saiz, A, Fortea, J, Llufriu, S. Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients. Scientific Reports. 2021; 11(1)DOI:10.1038/s41598-021-96132-x. PMID:34413373. IF:4.997(Q2/3D).
Cognitive discrepancy patterns and their association with psychosocial functioning across affective disorders.
Vicent-Gil M, Serra-Blasco M, Trujols J, Navarra-Ventura G, de Diego-Adeliño J, Puigdemont D, Alemany C, Pérez J, Portella MJ, Cardoner N. Cognitive discrepancy patterns and their association with psychosocial functioning across affective disorders.. Spanish Journal Of Psychiatry And Mental Health. ; DOI:10.1016/j.sjpmh.2025.05.001. PMID:40886773. IF:(Q/D).